![blood serum samples](http://media.assettype.com/healthday-en%2F2024-05%2F6dd15958-9f69-4593-b096-973a49236506%2FAdobeStock_433601452.jpg?w=480&auto=format%2Ccompress&fit=max)
FRIDAY, May 31, 2024 (HealthDay News) -- Maternal serum alpha-fetoprotein (AFP) levels are higher in Black than White pregnant women, supporting the use of accounting for these differences in prenatal open neural tube defect (ONTD) screening, according to a study published online May 23 in Clinical Chemistry.
Geralyn Messerlian, Ph.D., from the Women & Infants Hospital and the Alpert Medical School at Brown University in Providence, Rhode Island, and colleagues conducted a retrospective analysis on deidentified prenatal screening records to compare ONTD screening performance with and without accounting for race. A sample of 13,316 records for analysis had an ultrasound-confirmed gestational age between 15 and 21 completed weeks, singleton pregnancy, and self-reported race.
The researchers found that AFP levels for pregnancies were higher in Black than White individuals (6 to 11 percent depending on gestational age). Similar screen-positive rates were seen for self-reported White and Black individuals in race-specific gestation age and maternal weight analyses at 0.74 versus 1.00 percent, respectively. However, in race-agnostic analyses, the screen-positive rate was 2.4 times higher in Black than White individuals.
"Our results, together with existing professional recommendations and other current publications, endorse the continued use of self-reported race in prenatal serum screening," the authors write.
One author disclosed ties to the biotechnology industry.